Aims Altering the length of time specimens are placed in fixative without compromising analytical testing accuracy is a continuous challenge in the anatomical pathology lab. The aim of this study was to determine under controlled conditions the effects of variable fixation time on breast biomarker expression in human breast cancer cell line-derived xenografted (CDX) tumours.
Methods CDX tumours using strong oestrogen receptor (ER)-positive, Her2-negative (MCF7) and weak ER-positive, Her2 equivocal (T47D) breast cancer cell lines were fixed for various times ranging from 1 to 336 hours in 10% neutral buffered formalin. CDX tumours were processed according to routine biomarker testing protocols and stained for ER and Her2 immunohistochemistry (IHC) and processed for HER2 fluorescence in situ hybridisation (FISH). The tumours were evaluated using Allred scoring for ER and current ASCO/CAP guidelines for Her2, and by objective cell counting methodology.
Results No differences were found in expression of ER in either MCF7 or T47D CDX tumours under variable fixation. T47D tumours displayed variably equivocal Her2 staining when fixed for 24 hours, but fixation for ≤8 hours resulted in consistently negative staining while tumours fixed for >72 hours demonstrated consistent equivocal staining (p<0.01). Cell counting assays revealed only a significant increase in sensitivity in tumours fixed for >72 hours (p<0.01). As expected, FISH results were unaffected by variable fixation.
Conclusions Neither shortened nor prolonged fixation affects ER expression, consistent with previous findings. In equivocal Her2-expressing tumours, however, increasing fixation increased the sensitivity of Her2 IHC reporting while not affecting FISH.
- BREAST CANCER
- IN SITU HYBRIDISATION
Statistics from Altmetric.com
Correction notice This article has been corrected since it was published Online First. The authors affiliations and the author, P Erivwo's name has been corrected.
Handling editor Runjan Chetty
Contributors KRK designed experiments, collected and interpreted data, wrote the manuscript and supervised research. TH performed all xenograft experiments, collected data and assisted in manuscript preparation. AB performed FISH analysis, collected and interpreted data and contributed to writing of manuscript. TT performed initial fixation audit and collected data. LG interpreted data and contributed to manuscript preparation. ACS designed experiments and contributed to manuscript preparation. SL, PG and KV collected data. PE, JP and ND interpreted data.
Funding Newfoundland & Labrador Centre for Applied Health Research (Enhancing Health in Newfoundland and Labrador).
Competing interests None declared.
Ethics approval HREA Newfoundland and Labrador.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement All data generated by this study are presented either in the text or as online supplementary information.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.